Accueil Ernstrade Bourse Actualite Stock


Place de cotation: IIN - London

The Group's principal activity is to develop and commercialise polymer implants for the orthopaedic fixation market. The Group's expertise and technology lies in the design and manufacture of biodegradable polymer devices, such as plates, screws, pins and membranes. These implants are used to enhance the healing of skeletal injuries, such as those caused by trauma or by reconstructive surgery. The Group has four operating segments: Craniomaxillofacial Surgery, Orthopaedic Trauma, Sports Medicine and Dental Surgery. Product brands include Hexalon, Trinion, OTPS Pin, OTPS Ankle Fixation, OTPS Mesh, OTPS Min-Planting, Compact Planting System, Optima and Optimaplus. The Group operates in Europe, Americas, Asia, Australia and Pacific area.


Copyright  2016  Ernstrade